Form 8-K - Current report:
SEC Accession No. 0000944809-22-000043
Filing Date
2022-08-16
Accepted
2022-08-16 17:03:45
Documents
13
Period of Report
2022-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20220816.htm   iXBRL 8-K 43406
2 EX-10.1 exhibit1018-16x22.htm EX-10.1 67350
  Complete submission text file 0000944809-22-000043.txt   265069

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20220816.xsd EX-101.SCH 1900
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20220816_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20220816_pre.xml EX-101.PRE 12511
7 EXTRACTED XBRL INSTANCE DOCUMENT opk-20220816_htm.xml XML 10812
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 221170937
SIC: 2834 Pharmaceutical Preparations